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Abstract 
In this study, we evaluated the effect of PEO/ 
PBT proportion on the behavior of a range of PEO/ 
PBT segmented copolymers (Polyactive) during subcu-
taneous and intrabony implantation in the rat. It was 
demonstrated that varying the PEO proportion affected 
degradation, calcification and bone-bonding. The 
PEO/PBT 70/30 and 60/40 showed extensive degrada-
tion after 1 year, PEO/PBT 55145 an intermediate deg-
radation, and the 40/60 and 30170 copolymers showed 
little and hardly any degradation respectively. PEO 
content also affected the degree of calcification . 
PEO/PBT 70/30 showed extensive and early calcifica-
tion whereas almost no calcification was seen with 
PEO/PBT 30170. Since calcified sites at the periphery 
of the polymeric implants were locations of preference 
for bone-bonding to occur, PEO/PBT proportion also 
influenced bone/PEO/PBT interactions . The materials 
with the highest PEO content most frequently showed 
morphological indications of bone-bonding , while the 
material with 30 % PEO showed no bone/biomaterial 
contact. The differences in bone-bonding activity 
were also reflected by the occurrence of an electron. 
dense zone at the bone-biomaterial interface which was 
morphologically similar to that observed for calcium 
phosphate ceramics. 
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Introduction 
For alloplastic materials , bone-bonding is a 
property that has been mainly attributed to certain 
calcium phosphate ceramics [6, 19, 21, 24] and so 
called glass ceramics and Bio glass [20, 22]. Further-
more, specific surface reactions on titanium might also 
place this material into the category of bone-bonding 
biomaterials [16]. Each of these materials has a high 
elastic modulus and the glasses and ceramics generally 
have a low fracture toughness. Evidently, the scope 
of clinical application of bone-bonding biomaterials 
would be widened by the availability of materials with 
a lower elastic modulus, for instance elastomeric poly-
mers. 
Until recently no bone-bonding polymers were 
available and most efforts directed towards obtaining 
materials with a lower elastic modulus than glasses 
and ceramics has led research groups to pursue the 
manufacturing of bone-bonding composites. In these 
composites, the bone-bonding glasses or ceramics are 
added as a filler [10] or a coating to a polymeric or 
metallic substrate [15, 31, 34] and this approach 
seems to be successful. However, the scope of bone-
bonding biomaterials would be even further widened 
by the availability of a polymer which possesses bone-
bonding properties without the addition of bone-
bonding agents. 
Recently Bakker et al. [2 , 3, 4] described that a 
specific Poly(ethylene oxide hydantoin) Poly(butylene 
terephthalate) segmented copolymer (HPEO/PBT 551 
45), with a 55/45 distribution in weight between the 
two segments, possessed properties that fitted in the 
bonding osteogenesis theory of Osborn and Newesly 
[25]. When implanted in a porous form near the bony 
middle ear bulla of the rat, the HPEO/PBT 55/45 co-
polymer (also known under the trade name Polyactive) 
showed an intimate contact with bone without an inter-
vening fibrous tissue layer [2]. Furthermore, bone 
deposition and ingrowth started both from the periph-
ery and center of pores which fitted Osborn's "bioac-
tive" materials in contrast to the so called "biotole-
rated" materials which are characterized by distance 
osteogenesis. Another indication of the bone-bonding 
capacity of the HPEO/PBT 55/45 copolymer was its 
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similarity at the bone/biomaterial interface as com-
pared to hydroxyapatite ceramics [3]. An electron 
dense layer was found that showed continuity with the 
lamina limitans of bone [29] and was similar in mor-
phology to the bonding zone or electron dense layer 
observed at the hydroxyapatite/bone interface [7 , 12, 
17, 27]. By several authors, this layer is considered 
to play an important role in the bone bonding process. 
Recent studies have investigated the interactions 
with bone, of dense HPEO/PBT 55145 in comparison 
with PEO/PBT 55145 , lacking the hydantoin segment , 
together with two calcium phosphate ceramics and sili-
cone rubber [8, 9]. It was reported that both HPEO/ 
PBT 55145 and PEO/PBT 55145 bonded with bone as 
did the calcium phosphate ceramics. During pull out 
studies, the bonding strength at the bone/biomaterial 
interface exceeded the internal strength of both poly-
mers and ceramics. This study demonstrated that hy-
dantoin was not necessary for bone-bonding of the co-
polymer and can therefore be omitted in future stu-
dies. In addition, there seemed to be a relationship 
between the calcification of the polymer's surface and 
the occurrence of bone-bonding . At such areas , calci-
um phosphate crystals were seen to penetrate into the 
polymer , forming a continuity between the crystals in 
bone and the polymer, partially explaining the bone-
bonding mechanism. · 
Since calcification of the (H)PEO/PBT 55/45 
copolymer is possibly related to the PEO segment of 
the polymer , which as Polyether depending on its mo-
lecular weight, would be able to absorb calcium ions 
[32], we decided to investigate the effects of variation 
in PEO/PBT proportion . Special emphasis was placed 
on the assessment of degradation, calcification and 
bone-bonding, using light microscopy, scanning trans-
mission electron microscopy, X-ray microanalysis and 
image analysis. The PEO/PBT copolymers, varying in 
PEO proportion from 30% to 70%, were implanted in 
the form of dense blocks into the tibia and subcutis of 
the rat. Calcification was also quantitatively assessed 
on porous films during subcutaneous implantation in 
the same anir.tal. 
Materials and Methods 
Implant materials 
Five different PEO/PBT block copolymers dif-
fering in PEO/PBT proportion (PEO/PBT: 70/30, 
60/40, 55145, 40160 and 30170) were used. All poly-
mers were obtained through HC Implants BV (Leiden, 
The Netherlands). The polymers were in the form of 
dense smooth blocks (1.5 x 1.5 x 1.5 mm) with the ex-
ception of the 55145 and 30/70 which at the time of 
the study were only available in a cylindrical form of 
similar dimensions. Furthermore, all materials were 
also used as porous films. The molecular weight of 
the individual PEO segments was 1000 Dalton (D). 
Implantation site and procedure 
Both blocks and porous films were implanted 
24 
subcutaneously after dorsal incisions . Blocks were 
also implanted into the rat tibia, no press fit procedure 
was used and the implants were loosely inserted into 
the created defect (greater than ± 2 mm). Male Wis-
tar rats of 180-200 grams body weight were used. As 
post-operative evaluation intervals, we chose 3 weeks, 
6 weeks, 3 months, 6 months and 12 months. For 
each PEO/PBT proportion and implant type (blocks 
and films), 4 implants were used per implantation site 
and interval , thus representing a total of 200 blocks 
and 100 films distributed over 50 animals. 
Evaluation techniques 
As evaluation techniques , we used light micros-
copy , scanning electron microscopy (Philips 525), 
transmission electron microscopy (Philips 201 , 400, 
410), back-scattered electron microscopy , X-ray 
microanalysis (TN 2000, Voyager) and image analysis 
(Vidas) . Both decalcified and non-decalcified material 
were studied. All specimens were fixed in glutaralde-
hyde and those destined for transmission electron mi-
croscopy were post-fixed in 1 % osmium tetroxide . 
The films (4 per type and interval) were only analyzed 
by light microscopy and alizarin red staining (indica-
tive for calcium) while in the case of the blocks , two 
were used for light microscopy, one for scanning and 
one for transmission electron microscopy. Back-scat-
tered electron microscopy was mostly performed on 
either Epon or glycol methacrylate embedded blocks 
obtained after sectioning and on corresponding sec-
tions , all sputter-coated with carbon. A more elabo-
rate description of the techniques has been reported in 
earlier publications [8]. 
Determination of calcification 
For each implant type and postoperative inter-
val , 4 films were sectioned in 2 µm sections with a 
LKB Ultracut 2000 . Subsequently, 5 sections were 
analyzed by a Vidas image analysis system for the 
presence of calcium, based on alizarin red staining. 
The polymers were visualized by sudan black staining 
and/or polarized light and the tissue morphology and 
boundaries were assessed using a toluidine blue stain. 
Results 
Subcutaneous implantation 
General tissue reactions: All blocks showed 
similar reactions concerning the surrounding fibrous 
tissue when studied by light microscopy. Initially (3 
weeks) the blocks were partially surrounded by a 
loosely arranged fibrous tissue, incorporating some in-
flammatory cells (Fig. 1). After longer implantation 
times, a thin zone of dense fibrous tissue with collagen 
fibers running parallel to the surface was observed. 
Fibroblasts within the capsule assumed a similar orien-
tation . Although large areas near the implant surface 
lacked the presence of inflammatory cells, both macro-
phages and multinucleated cells could be observed at 
some locations . The use of scanning and transmission 
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electron microscopy confirmed these light microscopi-
cal findings. It should be emphasized that the above 
description of the tissue surrounding the implant large-
ly refers to those implants with their surface predomi-
nantly intact. After one year such an intact surface 
was only observed for the PEO/PBT 30/70 and 40/60 
copolymers. All other PEO/PBT proportions showed 
a clear alteration of the implant structure. 
Implant degradation: The first indications of 
a change in implant structure were observed for the 
PEO/PBT 70/30 copolymer. This polymer already 
showed degradation into relatively large fragments 
three weeks following implantation, which was most 
clearly observed by scanning electron microscopy. 
Due to the relatively large size of the individual frag-
ments most of the implant/tissue interface of this co-
polymer was still composed of a morphologically in-
tact polymer surface. At 6 weeks the degradation of 
PEO/PBT 70/30 had progressed and PEO/PBT 60/ 40 
showed the first signs of fragments detaching from its 
surface. All other PEO/PBT proportions were still 
generally intact, except for crack formation at their 
surface in a confined zone of approximately 10-100 
µm thickness . After 3 months , both the 70/30 and 
60/40 proportion showed extensive fragmentation 
throughout and fibrous tissue had filled the interfrag-
ment space. At this point in time, the PEO/PBT 55145 
also showed extensive crack formation and detachment 
of fragments from the implant surface although the im-
plant outline was still largely intact. Crack formation 
in the PEO/PBT 40/60 had proceeded but fragment de-
tachment was not yet apparent. The PEO/PBT 30/70 
did not reveal significant changes as compared to the 6 
weeks period. In the 6 month and 1 year periods, 
fragmentation had continued for the PEO/PBT 70/30, 
60/40 and 55/45 copolymer causing a smaller average 
particle size in the course of time. For the PEO/PBT 
70/30 proportion , fragmentation was so extensive that 
the implants were difficult to retrieve after 1 year. 
The PEO/PBT 40/60 and 30/70 did not show a signifi-
cant deviation from the 3 month period with exception 
of the occurrence of a single deep crack in one of the 
40/60 implants after one year. Figures 2a-d show the 
sit uation for the various PEO/PBT proportions after 
long term implantation. With exception of the 1 year 
PEO/PBT 70/30, the original contours of the implants 
could still be observed despite the fact that tissue had 
grown into the interfragment space. This indicated 
that the disappearance of implant material from the ac-
tual implantation site, was either by cellular transport 
or actual resorption. Light microscopical surveys of 
general degradation are shown in Figures 3a-c. 
Cellular reactions during degradation: The 
degradation found for the different PEO/PBT propor-
tions had major consequences for the tissue that sur-
rounded the implants and penetrated into the interfrag-
me nt space. Light microscopy revealed that , in the 
early stages of fragment detachment , phagocytes were 
present near the implant surface with implant particles 
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Figure 1. Light micrograph of a dense 70/30 PEO/ 
PBT implant (I) after 6 weeks of subcutaneous im-
plantation. Bar = 150 µm. 
in their cytoplasm. As fragmentation continued, these 
cells were also seen in the interfragment spaces. The 
more extensive fragmentation became, the more prom-
inent these cells were and the higher their extent of 
cytoplasmic loading. Eventually, the phagocytes in 
the heavily degrading PEO/PBT proportions assumed a 
foam cell appearance. Transmission electron micros-
copy showed the extent of phagocytosis of implant ma-
terial even more clearly (Fig. 4). In spite of the heavy 
loading of these cells with implant fragments, their 
general morphology remained relatively normal (Fig. 
5). The nucleus was always intact and all cell or-
ganelles were present. The high amount of, frequently 
dilated, rough endoplasmic reticulum and mitochon-
dria suggested a high metabolic activity. The orienta-
tion and morphology of fragments in the cell cyto-
plasm sometimes suggested that fragmentation would 
even continue within the cytoplasm. 
Subcutaneous calcification 
General observations: When investigating the 
polymers, it was observed that zones were present in 
the polymer that stained positive during alizarin red 
staining, indicating the presence of calcium. The 
presence of both calcified spots and larger calcified 
areas with quite frequently spots at their internal 
periphery (Fig. 6) suggested that calcification started 
by focal points gradually leading to larger calcified 
areas. Calcified areas were also clearly visible using 
scanning electron microscopy combined with single 
spot analysis or with backscatter electron microscopy 
(Figures 7a-d; at color plate page 33). The composi-
tion of these calcified areas will be further elucidated 
below when discussing the interactions of the PEO/ 
PBT copolymers with bone. Calcification was more 
prominent with increasing PEO content and no calcifi-
cation was observed with the 30/70 copolymer. 
Quantification of calcification: Since quanti-
tative evaluation of the calcification in the blocks was 
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difficult to perform, we decided to use the porous 
polymer films for quantitation. In general, the films 
showed an apparently faster degradation than the 
blocks . Due to this rapid degradation, it was no long-
er possible to retrieve the 70/30 films after periods 
longer than 3 months. The polymers were well recog-
nized by sudan black staining and calcification was as-
sessed by alizarin red staining (Fig. 8). The results, 
obtained after image analysis, are shown in Fig. 9 
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Figure 2 (facing page, left). Scanning electron mi-
crographs of different dense PEO/PBT implants after 
subcutaneous implantation. Sometimes the porous 
film is also visible. I = dense implant, p = porous 
film. a) PEO/PBT 30/70, 1 year after implantation 
showing no noteworthy signs of degradation. Bar = 
0.63 mm. b) PEO/PBT 40160, only shows confined 
crack formation after 1 year of implantation. Bar = 
0.56 mm. c) PEO/PBT 60140 with prominent frag-
mentation, 1 year after implantation. Bar = 0.67 mm. 
d) PEO/PBT 70/30, characteristically showed exten-
sive fragmentation and disappearance of bulk material, 
6 months after implantation. Bar = 0.69 mm. 
Figure 3 (facing page right). Light micrographs of 
increasing stages of fragmentation during subcutaneous 
implantation. C = calcified area (alizarin red stain-
ing). a) PEO/PBT 55/45 after 1 year of implantation. 
The first signs of fragmentation are seen in the form 
of crack formation of the interface (arrows). Bar = 
300 µm. b) PEO/ PBT 60/40 implanted for 1 year 
showing the second stage of fragmentation, more ex-
tensive surface erosion leading to detachment of im-
plant fragments (arrows). Bar = 300 µm. c) PEO/ 
PBT 70/30 after 1 year of implantation showing exten-
sive fragmentation throughout the polymer. Bar = 
300 µm. 
Figure 4 (at right, top). Phagocytes near the implant 
surface. (I) heavily loaded with polymer fragments 
(arrows). Transmission electron micrograph. Bar = 
3.1 µm. 
Figure 5 (at right, middle). A more detailed micro-
graph of the cytoplasm of a cell that phagocytosed 
PEO/PBT 70/30 (arrows) 6 months after subcutaneous 
implantation. Note the normal morphology of the cell 
organelles. Bar = 0.94 µm. 
which indicates that more PEO will lead to increased 
calcification. This seems to suggest that an increase 
in PEO content will also lead to earlier calcification. 
In correspondence with the blocks, no calcification 
was found for the 30/70 copolymer. It was interesting 
to note that with the exception of the PEO/PBT 40/60 
copolymer, none of the implanted films showed signif-
icant calcification at the 3 month period. In contrast, 
calcification could still be found with the blocks at this 
stage. 
Implantation into the tibia 
The degradation behavior of the PEO/PBT co-
polymers has already been discussed in the Subcuta-
neous implantation section above. The mechanism of 
degradation in bone did not significantly deviate from 
that in the subcutaneous implantation site, although it 
generally seemed less prominent, therefore degrada-
tion will not be further discussed in this section and 




Figure 6. The interfacial zone of a PEO/PBT 55145 
with fibrous tissue after 1 year of implantation. Ex-
tensive calcification (C) is found near the implant sur-
face with spot-like calcification seen at greater dis-
tances (arrow). Bar = 60 µm. 
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Table 1. Degradation of PEO/PBT copolymers after 3 and 6 weeks (w), and 3, 6, and 12 months (m). 
PEO/PBT 3w 6w 3m 6m 12m 
70/30 +++ +++ ++++ ++++ +++++ 
60/40 + ++ +++ ++++ ++++ 
55/45 - + ++ +++ +++ 
40/60 - - + + +/++ 
30/70 - - - - -






Crack formation within bulk of material 
Fragments detaching from surface 
Fragmentation into large particles 
Degradation into smaller particles 
Extensive degradation 
Light microscopical evaluation of the various 
PEO/PBT implants showed rather similar reactions. 
All implants were covered by fibrous tissue, bone 
marrow, and bone. The bone was of a lamellar type 
and after longer implantation times, large parts of the 
polymer were covered by this type of tissue (Fig. 10). 
Evaluation of non-decalcified material: Anal-
ysis of the bone/biomaterial interface by scanning and 
transmission electron microscopy and backscatter elec-
tron microscopy in combination with X-ray microanal-
ysis showed that, with exception of the PEO/PBT 
30/70 copolymer, all copolymers had areas of intimate 
bone contact. With PEO/PBT 30/70 areas of contact 
were present at the light microscopical level, but this 
observation was never confirmed by electron micros-
copy. Electron microscopy always showed areas of 
non-calcified tissue either composed of cellular or 
collagenous material. Concerning the other polymers, 
it should be emphasized that the data were suggestive 
of an increase in the incidence of intimate contact, in 
time and in quantity, with increasing PEO content. 
However, due to the relatively small number of 
implants investigated, this presumption could not be 
proven. The general appearance of the bone-polymer 
interface is illustrated by the use of back-scattered 
electron microscopy in Figures 1 la-c (on color plate, 
at page 33) which shows a polished, non-decalcified, 
Spurr embedded PEO/PBT 60/40 implant, 3 months 
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after implantation. The X-ray maps provided in Fig. 
11 demonstrated that the tissue surrounding the 
implant in the marrow cavity was indeed composed of 
bone, as indicated by the presence of calcium and 
phosphorus signals. A higher magnification of the 
area near the cortex, combined with X-ray map (Fig-
ures 12a-c; at color plate on page 33), showed that the 
bone was in continuity with what seemed to be calci-
fied spots in the implant material. Analysis of these 
areas by transmission electron microscopy showed cal-
cified areas throughout the polymer and near bone. 
Higher magnifications demonstrated that such spots 
were composed of needle-like crystals. The similarity 
between the crystals in the polymer and those in bone 
is stressed by Figures 13a and b, which show a calci-
fied area in the polymer surface opposed to bone. 
Furthermore, an electron dense zone could sometimes 
be seen at the interface in these locations. 
Analysis of decalcified material: Study of the 
decalcified bone/PEO/PBT copolymer interface was 
predominantly performed with transmission electron 
microscopy . Although the morphology of the interface 
showed some variation, an interesting structure was 
seen at the interface of all materials except for the 
30/70 PEO/PBT copolymer. This latter material never 
showed a clear contact with bone and sometimes a 
non-calcified lamellar structure was seen interposed 
between bone and the polymer (Fig. 14a). At the 
PEO ratio affects Polyactive/tissue interactions 
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Figures 7, 11, & 12 are on color plate, page 33. 
Figure 8 (top left). Light micrograph showing a 
porous PEO/PBT 60/40 film after 6 weeks of implan-
tation. The major part of the implant fragments are 
calcified as indicated by the Alizarin red staining 
(arrows). Bar = 250 µm. 
Figure 9 (middle left). Diagram showing the calcifi-
cation in different PEO/PBT proportions as a percent-
age of total PEO/PBT surface. 
Figure 10 (bottom left). Light micrograph showing a 
general view of a decalcified PEO/PBT 60/40 interface 
with bone after 6 months. Bar = 60 µm. I =implant, 
b =bone. 
Figure 13 (above). a) Transmission electron micro-
graph of the non-decalcified PEO/PBT 60/40 interface 
with bone after 3 months. Note the presence of small 
needle-like crystals in both the bone (b) and the im-
plant (I). Note the electron dense zone at the interface 
(arrows). Bar = 1.1 µm. b) Spot analysis (at *) 
shows the presence of Ca and P throughout the 
polymer. Copper peaks are from the grid. 
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bone/biomaterial interface of all materials with a PEO 
content of 40% per weight or more, an electron dense 
deposit was encountered. In the case of the PEO/PBT 
40/60, this zone was composed of focal floccular ma-
terial but it was unclear whether it was located on the 
surface or also in the implant material (Fig. 14b). A 
similar structure was found with the PEO/PBT 55/45 
material, however, it was more continuous and fre-
quently had a multilayered structure above (Fig. 14c). 
The PEO/PBT 60/40 mostly lacked the floccular de-
posit found with the 55/45 and 40/60 materials, here 
only a prominent multilayered structure was seen (Fig. 
14d). A similar structure was observed with the PEO/ 
PBT 70/30 copolymer (Fig. 14e). With the latter type 
of material, it was characteristic that part of the multi-
layered electron dense structure was located in the ac-
tual polymer. This latter phenomenon was never 
clearly demonstrated for the other PEO/PBT propor-
tions . 
Discussion 
Varying the PEO/PBT proportion of PEO/PBT 
copolymer had several effects. First, PEO/PBT pro-
portion directly influenced the degradation rate of the 
copolymer. The fastest degradation rate was observed 
for the PEO/PBT 70/30 copolymer, which was almost 
completely degraded after 1 year, while the PEO/PBT 
30/70 showed hardly any degradation at all after this 
period. The other copolymers showed an intermediate 
degradation which increased with PEO concentration 
(Table 1). The mechanism of degradation is still not 
completely clear but based on our current knowledge it 
seems to comprise at least two factors . The first in-
volves hydrolysis of the polymer matrix which will at-
tack the ester bonds in the polymer. Varying the 
PEO/PBT proportion can influence hydrolysis in more 
than one way. It will change the amount of available 
ester bonds and by increasing the PEO content of the 
copolymer it, being a hydrogel, will take up more 
water thus facilitating the hydrolysis process. The 
second process involves a surface erosion as reported 
in this study. Fragmentation initially starts at the 
material surface, presumably by mechanical factors, 
and then proceeds to the core of the implant. At the 
surface of each fragment degradation will continue in 
a similar way. The consequence of these two factors 
would be that, if an implantation site influences the 
polymers accessibility to water or the mechanical fric -
tion at its surface (i.e., between material and subcuta-
neous layer), then this might affect the implants degra-
dation rate. Of course, other mechanisms of deg-
radation, such as enzymatic attack, also need to be 
investigated. 
The degradation and fragmentation of the poly-
mer has consequences for its general biocompatibility . 
It was striking to observe that fragmentation led to ex-
cessive phagocytosis of fragments by cells that even-
tually assumed the morphology of foam cells. This in-
dicated that cells could still phagocytose despite the 
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presence of relatively high amounts of material that 
had already been phagocytosed. In general, cell mor-
phology remained intact and, in spite of the sometimes 
extensive fragmentation, no local inflammatory re-
sponse was observed other than the presence of the 
phagocytosing cells. These data deviated from find-
ings described for polylactide and associated poly-
mers, where an extensive inflammatory reaction was 
reported during the degradation stage [4, 28] . Since 
substantial degradation of the PEO/PBT copolymers 
can occur, it will be necessary to further analyze the 
degradation route and products. However, the experi-
mental data and those in the literature do not indicate 
any adverse effects associated with degradation of 
these copolymers [l, 4, 5, 18, 26, 30, 35]. 
Varying the PEO/PBT ratio did not only influ-
ence degradation rate but also the calcification of the 
polymer. Calcification of polymers is a well known 
phenomenon and several studies have been dedicated 
to preventing this. Part of those studies indicate that 
PEO or PTMO homopolymers with a molecular weight 
of 1000 D showed a peak in calcium absorption [32]. 
The molecular weight of the PEO used in this study 
was 1000 D and as the calcification rate increased with 
PEO content, it is likely that calcification of the 
PEO/PBT copolymer is indeed related to calcium ab-
sorption by the PEO fragment. It was interesting to 
note that the quantitative assessment of calcification in 
the porous films indicated that it was a reversible 
process, at least in soft tissue. With the exception of 
the PEO/PBT 40/60, which apparently shows an over-
all delayed and less distinct reaction, no significant 
calcification was found at implantation periods of 
three months and more. It should be emphasized, 
however , that the quantitation was only based on po-
rous films · after subcutaneous implantation and other 
implant shapes and/or implantation sites may show dif-
ferent calcification patterns. This was actually con-
firmed by the fact that extensive calcification could 
still be found in the dense blocks after longer implan-
tation times irrespective of the fact whether they were 
implanted subcutaneously or in bone. Although calci-
um absorption by the PEO segment must play a role in 
the calcification it is still not clear how the precipi-
tation of calcium phosphate occurs and why it occurs 
at specific sites, such as just beneath the surface of the 
implant material. The data presented in the current 
study suggest that calcification initially occurs by the 
formation of needle-shaped calcium phosphate crys-
tals , not unlike hydroxyapatite, in mineralization nod-
ules. In later stages, the merging of mineralization 
nodules might lead to the larger calcified areas which 
were frequently observed near the surface or in the 
center of the dense blocks. 
Calcification near the surface of the polymers 
plays an important role in the bone-bonding process. 
This is stressed by the fact that our current data sup-
port the view that PEO/PBT 30170, which shows no 
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Figure 14. The interface between bone and different 
PEO/PBT proportions. All specimens were decalci-
fied prior to embedding . Note the electron dense 
structure at the bone/PEO/PBT interface. An inter-
posed fibrillar zone was always found between bone 
matrix and PEO/PBT 30/70. I = implant, b = bone. 
a) PEO/PBT 30170, 6 months. Bar = 0.28 µm. 
b) PEO/PBT 40/60, 6 weeks. Bar = 0.37 µm . 
c) PEO/ PBT 55/45 , 6 weeks. Bar = 0.20 µm . 
d) PEO/PBT 60/40, 6 weeks . Bar = 0.38 µm. 
e) PEO/PBT 70/30, 6 weeks . Bar = 0.41 µm. 
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contact with bone at its interface. All other PEO/PBT 
proportions used in this study, that did calcify, did 
show such an intimate contact with bone. Further-
more, the relationship between bone-bonding and cal-
cification became clear by two other observations. 
First, the materials that showed most calcification 
were also characterized by the most bone/biomaterial 
contact, although it should be emphasized that this was 
only assessed subjectively and needs quantitative sup-
port. Second, many sites of intimate contact with 
bone were found at sites of copolymer calcification. 
Possibly a calcified surface is a preferential site of 
bone contact. Further analysis of the non-decalcified 
bone/biomaterial interface showed a "continuity" be-
tween the hydroxyapatite crystals of bone and the cal-
cium phosphate crystals in the polymer. This continu-
ity might at least partially explain the bonding that oc-
curs at the interface and is not unlike the bonding 
mechanism described for both "bioactive" glasses and 
ceramics (7, 11, 20, 23, 25, 33]. 
This similarity between the more traditional 
bone-bonding biomaterials and PEO/PBT copolymer 
was not confined to the non-decalcified interface but 
extended to the decalcified interface as well. Bakker 
et al. [3] have described that investigation of the 
(H)PEO/PBT copolymer/bone interface revealed a 
structure that was similar to the electron dense zone 
found for hydroxyapatite ceramic at sites of bone con-
tact. The exact composition of this structure is still 
not completely clear but it is composed of organic ma-
trix (rich in glycosaminoglycans) (12], anorganic 
material (calcium phosphate crystals) [7], is related to 
the lamina limitans of bone (27], and shows some sim-
ilarities with cement lines and/or reversal lines (14]. 
Several authors assume that there might be a relation-
ship between the occurrence of bone bonding and the 
presence of this particular structure, therefore, it was 
interesting to note that the non bone-bonding PEO/ 
PBT 30/70 did not show such a structure. Further-
more, the morphology of the electron dense zone with 
the other polymers was clearly related to the PEO/PBT 
proportion. The PEO/PBT 70/30 was characterized by 
a multilayered structure clearly penetrating the mate-
rials surface whereas the PEO/PBT 40/60 only showed 
an electron dense focal deposit. The PEO/PBT 55/45 
showed a combination of the previous two polymers in 
the shape of both an electron dense deposit, albeit 
more continuous, and a multilayered structure. This 
difference in morphology of the electron dense layer at 
the bone/biomaterial interface seen for PEO/PBT co-
polymer corresponds with the variations reported for 
this structure with calcium phosphate ceramics that 
vary in crystal structure [6, 7, 13]. 
In conclusion, it can be stated that variation in 
PEO/PBT proportion will change the degradation rate, 
calcification and bone bonding capacity of PEO/PBT 
copolymers. Future studies will be directed towards 
the quantification of this phenomenon and to inves-
tigate whether variations in molecular weight of the 
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Figures 7, 11, and 12 on color plate, page 33. 
Figure 7. Ultrastructural analysis of PEO/PBT calci-
fication. a) Calcified spots as seen by scanning elec-
tron microscopy at the surface of a PEO/PBT 70/30 
fragment, 3 months after subcutaneous implantation. 
Bar = 2 µm. b) A cross-section of spot-like calcified 
areas within PEO/PBT 60/ 40 after 1 year subcutane-
ously. Note the needle-like crystallites. Bar = 1.6 
µm. c) Back-scattered electron micrograph of a calci-
fied spot (*) within PEO/PBT 55145 just below the 
surface after 3 months of subcutaneous implantation. 
Bar = 31.7 µm. d) X-ray map indicating the presence 
of calcium in the structure shown in Figure 7c. 
Figure 11. a) Back-scattered electron micrograph of 
an undecalcified PEO/PBT 60/40 after 3 months im-
plantation. I =implant, b =bone. Bar = 0.6 µm. b 
and c) X-ray maps indicating the presence of calcium 
(b) and phosphorus (c). 
Figure 12. More detailed back-scattered electron mi-
crograph. I =implant, b =bone. Bar = 52 µm. a) 
undecalcified PEO/PBT 60/40 after 3 months. b and 
c) X-ray map indicating the presence of calcium (b) 
and phosphorus (c). 
PEO segment will affect the aforementioned properties 
in a way similar to variations in PEO/PBT proportion. 
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Discussion with Reviewers 
J.M. Sau tier: Different bonding zones are shown at 
the transmission electron microscopy (TEM) level. 
Do you think that there is a relationship between the 
bone-bonding quality and the morphology of the inter-
face? Have you , for example, estimated the bone-
bonding by pull-out tests? 
Authors: We indeed feel that there is a relation be-
tween the bone-bonding quality and the morphology of 
the interface. Especially in some more recent (unpub-
lished) studies we were well able to demonstrate that 
more bone-ingrowth and interfacial contact would be 
obtained when using PEO/PBT copolymers that 
showed high rates of calcification . Since such poly-
mers also showed a more prominent structure at the 
interface with bone, one would tend to think that there 
is a relation between interfacial morphology and quali-
ty of bonding. Also some recent studies on several 
calcium phosphate ceramics were indicative for a de-
layed appearance of the electron dense structure with 
slowly degrading coatings, like fluoroapatite, indicat-
ing that a relation with the activity of the ceramic is 
indeed present. Concerning the use of pull-out stud-
ies , although this seems to be interesting it is actually 
quite complicated due to the fact that with different 
PEO/PBT proportions the materials will also have dif-
ferent mechanical properties which would make a cor-
rect interpretation of pull-out data very complicated, if 
possible at all. 
J.M. Sau tier: Calcium absorption by the PEO seg-
ment seems to play a role in the calcification of the 
polymer, however the mechanism of Ca-P formation is 
not clear. In vitro studies could provide, in the fu-
ture, more information on this process, particularly if 
the presence of cell is necessary for polymer calcifica-
tion. 
Authors: We agree with you. Such studies are cur-
rently in progress. 
J.M. Sautier: When looking at the different morphol-
ogy of the bone-bonding zone at the TEM level, do 
you think there is a relationship between the degrada-
tion rate of the polymers and the structure of the elec-
tron-dense layer? In this connection, do you think that 
degradation of the implant and products released into 
tissues will have a biological effect? 
Authors: We believe that there exists a relation be-
tween calcification and the appearance of the interfa-
cial structure. Since the polymers that show most cal-
cification do also degrade the fastest, there is indeed a 
relation, although presumably indirect, between degra-
dation and the occurrence of the electron dense layer. 
It might potentially be so that a release of 
terephthalate from the polymer during degradation 
would , due to a low solubility product, lead to a calci-
um terephthalate precipitation which might then trig-
ger a further calcium phosphate precipitation. Such a 
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precipitate might then affect the interfacial cellular 
phenotype. With the exception of the release of 
terephthalate during degradation, which has been dem-
onstrated, this assumption is up to now purely 
hypothetical. 
J.M. Sautier: Since calcification of the copolymer 
occurs in non-osseous sites, do you think that these 
materials can be qualified as "osteoinductive"? 
Authors: So far we do not have any indications for a 
osteoinductive nature of these polymers. Their 
activity seems to be confined to osteoconductivity. 
J.M. Sau tier: You clearly demonstrated that PEO/ 
PBT influenced the degradation rate of the copolymer. 
Do you think that these biomaterials could be also 
used for clinical application as delivery systems? 
Authors: We are currently investigating the potential 
of this class of polymers as a drug delivery device. 
The first pilot studies indicate that, through some ad-
aptations, these polymers might indeed be a valuable 
asset to the already available drug delivery polymers. 
T. Kitsugi: In discussing Figure 12, you state 
"Higher magnifications demonstrated that such spots 
were composed of needle-like crystals"; this statement 
is subjective since there is no evidence. It is very 
difficult to define crystals and state their nature from 
the morphological observations alone, it is necessary 
to use the X-ray diffraction to characterize a crystal! 
Authors: To see that the crystals are present (and to 
recognize their shape), poses no problem with the 
techniques we currently use; determining their nature 
is another matter. This is currently the subject of a 
different study where we are using X-ray diffraction, 
infrared spectroscopy, and high resolution TEM to in-
vestigate the crystal structures. 
T. Kitsugi: It is difficult to conclude degradation 
from the observation of the crack since there is a pos-
sibility that the crack may have occurred during the 
process of making the samples. 
Authors: Although this might indeed be a preparation 
artefact, it should be realized that it was only found 
for this specific PEO/PBT proportion after a specific 
post-operative interval. In other words, it is indica-
tive for specific material changes. 
T. Kitsugi: In Figure 14, it is very hard to distin-
guish the difference between the various micrographs 
showing the electron dense structures at the interfaces 
of these PEO/PBT copolymers. Could you please 
elaborate on that. 
Authors: As explained in Results, there seems to be 
a clear trend relating to these electron dense inter-
facial structures. Whereas, the structure is very 
prominent with a soft material, such as PEO/PBT 
70/30, in which case, it even clearly penetrates the 
implant surface; it gradually becomes less prominent 
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(thinner) when the implant contains more hard seg-
ment. Furthermore, with the PEO/PBT 55/45 we see 
the appearance of another more electron dense and 
floccular material at the interface together with the 
structure showing fine granular morphology that char-
acterized the softer materials. With the PEO/PBT 
40/60 this floccular material is the only characteristic 
interfacial structure in the absence of the finer pre-
cipitate. 
The micrograph of the PEO/PBT 30/70 (Fig. 
14a) deserves a special explanation. First of all this is 
from a sample after the 6 month evaluation period in 
contrast to the 6 weeks for the other PEO/PBT propor-
tions shown in Figures 14b to 14e. This was so be-
cause, before this period, no interfacial contact was 
observed between the bone and the implant. Although 
at first sight, the structure seems rather similar to that 
seen for the PEO/PBT 60/40, it should be noted that it 
is composed of very distinct lamellar structures in 
comparison to the more granular appearance of the 
other structure. In addition, we never found a bone -
PEO/PBT 30/70 contact with non-decalcified sections 
which indicates that this structure is most likely non-
calcified. 
T. Kitsugi: Glass-ceramics containing apatite and 
wollastonite is now used as an artificial bone in verte-
bral body. . .. Dr. Kokubo (Kyoto University) pub-
lished a new coating method of apatite to polymer 
[Kokubo T (1992). Bioactivity of glasses and glass ce-
ramics. In: Bone-Bonding Biomaterials. Reed Health-
care Publications, Leiderdorp, Netherlands, 31-46] 
Authors: Thank you for your comment. 
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